United States· US:62135-943_499eab19-cf6f-dfcd-e063-6294a90acc1d
Memantine Hydrochloride
A memantine product containing memantine hydrochloride, registered in United States by Chartwell RX, LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Memantine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Memantine · ATC N06DX01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of memantine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.
- United States: $0.22 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Memantine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- ES Spain$2.93
- CH Switzerland$2.47
- IT Italy$0.77
- US United States$0.22 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MEMANTINE HYDROCHLORIDE
- Manufacturer
- Chartwell RX, LLC
- Country
- United States (US)
- ATC code
- N06DX01
- ATC class
- Memantine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1162135-943-24
- ndc1162135-943-37
- ndc1162135943242 TRAY in 1 BOX (62135-943-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-943-05)
- ndc116213594337240 mL in 1 BOTTLE (62135-943-37)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
139 interactions on record for memantine.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Memantine · interactions on record
139 records
- 42 moderate
- 11 minor
- 80 info
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Memantine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAXURAMerz Pharmaceuticals GmbH, Frankfurt am Main
- SpainALSEMORA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGGrindeks As
- United KingdomAlzhok 10mg soluble tabletsGlenmark Pharmaceuticals Europe Ltd
- PolandAuroMemoAurovitas Pharma Polska Sp. z o.o.
- NetherlandsAlsemora 10 mg filmomhulde tablettenGrindeks AS
- FinlandAdaxor AloituspakkausAvansor Pharma Oy
- BelgiumAlsemora 10 mgGrindeks
- SwedenAlsemora 10 mg Filmdragerad tablettAS GRINDEKS
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Alsemora, Memantin 1a Pharma
- Belgium · Alsemora, Memantine Eg
- Bulgaria · Memantine Grindeks, Имана
- Cyprus · Alzedem, Mantomed
- Czechia · Cognomem, Mantomed
- Germany · Alsemora, Memantin
- Denmark · Alsemora, Marbodin
- Estonia · Alsemora, Mantomed
- Spain · Alsemora, Mantinex
- Finland · Alsemora, Marbodin
- France · Alsemora, Memantine Arrow Lab
- United Kingdom (Northern Ireland) · Memantine, Memantine Dawa
- Greece · Almerzac, Alsemora
- Croatia · Alsemora, Mantomed
- Hungary · Memantin Goodwill, Memantin Stada
- Ireland · Memantine Clonmel, Memantine Grindeks
- Iceland · Axura, Ebixa
- Italy · Demenco, Ezemantis
- Liechtenstein · Axura, Memantine Accord
- Lithuania · Alsemora, Maryzola
- Luxembourg · Memantine Eg
- Latvia · Alsemora, Mantomed
- Malta · Memantine Aurobindo, Memantine Clonmel
- Netherlands · Alsemora, Mantomed
- Norway · Alsemora, Axura
- Poland · Auromemo, Biomentin
- Portugal · Alsemora, Mantinex
- Romania · Alsemora, Memantina Atb
- Sweden · Alsemora, Marbodin
- Slovenia · Alsemora, Mantomed
- Slovakia · Alsemora, Mantomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cab4ce0a-3e63-481e-bf81-a52582b32e4c GET /v1/drugs/cab4ce0a-3e63-481e-bf81-a52582b32e4c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2",
"substance": "MEMANTINE HYDROCHLORIDE",
"productndc": "62135-943",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA204033",
"marketing_category": "ANDA"
}See everything about memantine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.